Shares of Compugroup Medical SE (ETR:COP) have earned an average rating of “Hold” from the six ratings firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and two have given a buy recommendation to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is €68.17 ($79.26).
COP has been the topic of several analyst reports. Berenberg Bank set a €75.00 ($87.21) price objective on Compugroup Medical and gave the company a “neutral” rating in a research note on Tuesday. Warburg Research set a €80.00 ($93.02) price objective on Compugroup Medical and gave the company a “buy” rating in a research note on Thursday, May 7th. Finally, Baader Bank set a €67.00 ($77.91) price target on Compugroup Medical and gave the company a “sell” rating in a research note on Wednesday, May 13th.
Shares of ETR COP traded down €2.00 ($2.33) during mid-day trading on Tuesday, hitting €71.35 ($82.97). The company had a trading volume of 133,760 shares, compared to its average volume of 68,245. The company has a market capitalization of $3.51 billion and a PE ratio of 60.47. The company has a debt-to-equity ratio of 177.81, a current ratio of 0.99 and a quick ratio of 0.78. Compugroup Medical has a 1-year low of €46.46 ($54.02) and a 1-year high of €78.50 ($91.28). The business’s 50-day simple moving average is €71.50 and its 200 day simple moving average is €63.35.
CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks.
Recommended Story: Why Dividend Stocks May Be Right for You
Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.